[Immunocorrective effect of cycloferon and thymogen in patients with uterine cancer].
Those women diagnosed as having hysterocarcinoma demonstrate even before surgery pronounced immunological disturbances tending to progress after surgical intervention. The employment of cyclopheronum and thymogenum makes for normalization of values for the immune status. Clinically, this is accompanied by a more favourable postoperative course.